Integer sells Advanced Surgical & Orthopedics business to Medplast
Berlin/ Zurich — Gleiss Lutz has advised Integer, the leading US medical device manufacturer worldwide, on the sale of its Advanced Surgical & Orthopedics business to MedPlast Group, a leading service provider to the medical device industry. The purchase price is $600 million. The transaction is subject to customary regulatory approvals, including antitrust clearances, and is expected to close in the third quarter of 2018.
New York Stock Exchange-listed Integer Holdings Corporation (NYSE: ITGR) is one of the world’s largest manufacturers of medical devices for cardiology, neuromodulation, orthopedics, vascular surgery and surgery, as well as mobile medical equipment. The company offers OEMs innovative, high-quality technologies and manufacturing processes. Integer also develops batteries for high-end niche applications for utilities, military and environmental applications. The company’s brands also include Greatbatch Medical, Lake Region Medical and Electrochem.
With the sale of the business, Integer expects to improve the company’s numbers with a profit of $1.2 billion with higher margins, higher net profits, higher returns on invested capital and significantly lower debt.
MedPlast Inc. based in Tempe, Arizona, provides product design and development, program and supply chain management for the delivery of finished medical devices and components. The company is also involved in the development and supply of implantable and biocompatible plastics.
Advisor Integer: Gleiss Lutz
The following Gleiss Lutz team led by Dr. Martin Viciano Gofferje (Partner, Corporate/M&A, Berlin) advised Integer on all aspects of German law in the transaction: Dr. Micha Pfarr, Svenja Bender (both Corporate/M&A, both Berlin), Dr. Stefan Lingemann (Partner), Dr. Rut Steinhauser, Dr. Katherina Wind (all Berlin, all Labor Law), Antonia Harbusch (Düsseldorf), Sergej Bräuer (Frankfurt, both Antitrust), Dr. Johann Wagner (Partner), Dr. Hendrik Marchal (Counsel, both Tax, both Hamburg) and Dr. Jacob von Andreae (Partner, Regulatory, Düsseldorf).
Back in 2015, Gleiss Lutz acted for Integer (then known as Greatbatch) on all aspects of German law in its acquisition of competitor Lake Region Medical from private equity investors KKR and Bain Capital for approximately $1.7 billion.